Globus Medical (GMED) was given a new $115.00 price target by Truist Financial Corporation.
Globus Medical (GMED) had its price target raised by Barclays PLC from $118.00 to $123.00. They now have an "overweight" rating on the stock.
Globus Medical (GMED) had its price target raised by Needham & Company LLC from $112.00 to $114.00. They now have a "buy" rating on the stock.
Globus Medical Inc (GMED) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]
Globus Medical: Q4 Earnings Snapshot [Yahoo! Finance]